These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19333988)

  • 1. Combined oral contraceptive use and the risk of systemic lupus erythematosus.
    Bernier MO; Mikaeloff Y; Hudson M; Suissa S
    Arthritis Rheum; 2009 Apr; 61(4):476-81. PubMed ID: 19333988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus.
    Meier CR; Sturkenboom MC; Cohen AS; Jick H
    J Rheumatol; 1998 Aug; 25(8):1515-9. PubMed ID: 9712093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects unrelated to disease activity and acceptability of highly effective contraceptive methods in women with systemic lupus erythematosus: a randomized, clinical trial.
    Cravioto MD; Jiménez-Santana L; Mayorga J; Seuc AH
    Contraception; 2014 Aug; 90(2):147-53. PubMed ID: 24815101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue diseases: Is combined oral contraceptive use linked to SLE incidence?
    Mok CC
    Nat Rev Rheumatol; 2009 Jul; 5(7):360-1. PubMed ID: 19568249
    [No Abstract]   [Full Text] [Related]  

  • 8. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.
    Sanchez-Guerrero J; Karlson EW; Liang MH; Hunter DJ; Speizer FE; Colditz GA
    Arthritis Rheum; 1997 May; 40(5):804-8. PubMed ID: 9153539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptives in women with systemic lupus erythematosus.
    Petri M; Kim MY; Kalunian KC; Grossman J; Hahn BH; Sammaritano LR; Lockshin M; Merrill JT; Belmont HM; Askanase AD; McCune WJ; Hearth-Holmes M; Dooley MA; Von Feldt J; Friedman A; Tan M; Davis J; Cronin M; Diamond B; Mackay M; Sigler L; Fillius M; Rupel A; Licciardi F; Buyon JP;
    N Engl J Med; 2005 Dec; 353(24):2550-8. PubMed ID: 16354891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
    Stanczyk FZ; Archer DF; Bhavnani BR
    Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL; Hughes GR
    J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.
    Seaman HE; de Vries CS; Farmer RD
    Pharmacoepidemiol Drug Saf; 2003; 12(7):541-50. PubMed ID: 14558177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M; Kroll R; Lynen R; Bangerter K
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.
    Sidney S; Petitti DB; Soff GA; Cundiff DL; Tolan KK; Quesenberry CP
    Contraception; 2004 Jul; 70(1):3-10. PubMed ID: 15208046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
    Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
    Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Trauma and Posttraumatic Stress Disorder With Incident Systemic Lupus Erythematosus in a Longitudinal Cohort of Women.
    Roberts AL; Malspeis S; Kubzansky LD; Feldman CH; Chang SC; Koenen KC; Costenbader KH
    Arthritis Rheumatol; 2017 Nov; 69(11):2162-2169. PubMed ID: 28929625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S; Kaye JA; Li L; Jick H
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.